XNYS
CL
Market cap72bUSD
Jul 09, Last price
91.01USD
1D
-2.18%
1Q
7.91%
Jan 2017
39.07%
Name
Colgate-Palmolive Co
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Colgate-Palmolive Company is a global consumer goods enterprise dedicated to the development, production, and distribution of a diverse array of products worldwide. The company's operations are divided into two primary business areas: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division offers a comprehensive range of daily necessities. This includes dental hygiene products like toothpaste, toothbrushes, and mouthwash; personal cleansing and grooming items such as bar and liquid hand soaps, body washes, shampoos, conditioners, deodorants, and specialized skin health solutions; and household maintenance goods like dishwashing liquids, fabric softeners, and general household cleaners. These products are marketed under numerous recognized brands, including Colgate, Darlie, Palmolive, Protex, Softsoap, Irish Spring, EltaMD, Filorga, Ajax, Fabuloso, and Suavitel, reaching consumers through a wide network of traditional and online retailers, as well as wholesalers and distributors. Additionally, this segment supplies pharmaceutical products specifically for dentists and oral health practitioners. The Pet Nutrition division focuses on animal well-being, providing nutritional products for daily dietary needs under the Hill's Science Diet brand, alongside a range of therapeutic formulas for managing various health conditions in dogs and cats, available through its Hill's Prescription Diet line. These specialized pet foods are distributed via pet supply stores, veterinary clinics, and e-commerce platforms. Colgate-Palmolive Company, established in 1806, maintains its headquarters in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||